Three years experience with post operative BCG adjuvant immunotherapy in stage II malignant melanoma is reported. Compared to a historical control group (35 cases), 23 melanoma patients showed a significantly improved remission duration and survival rate. It appears that patients with weak initial BCG reactions, which become gradually positive after several immunizations, get more benefit from the adjuvant immunotherapy than do patients with strongly positive initial BCG reactions.
Get full access to this article
View all access options for this article.
References
1.
BlumingA. Z., VogelC. L., ZieglerJ. L., ModyN., KamjaG.: Immunological effect of BCG in malignant melanoma: two modes of administration compared. Ann. Intern. Med., 76: 405–411, 1972.
2.
ComstockG. W., WebsterG. R.: Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population. Amer. Rev. Resp. Dis., 100: 839–845, 1969.
3.
Controlled study for prolonged chemotherapy, immunotherapy and chemotherapy plus immunotherapy as an adjuvant to surgery in stage I-II malignant melanoma: preliminary report.International Group for the Clinical Study of Melanoma, Milan.
4.
EilberF. R., MortonD. L., HolmesE. C., SparksF. C., RammingK. P.: Adjuvant immunotherapy with BCG in treatment of regional-lymph node metastases from malignant melanoma. New Eng. J. Med., 294: 237–240, 1976.
5.
FairleyG. H.: Immunotherapy in the management of leukaemia. Brit. J. Haemat., 31: 181, 1975.
6.
GrantR. M., CochranA. J., HoyleD., MackieR., MurrayE. L., RossC.: Results of administering BCG to patients with melanoma. Lancet, 2: 1096–1100, 1974.
7.
GuttermannJ. U., MavligitG. M., ReedR. C., BurgessM. A., McBrideC. M., HershE. M.: Adjuvant immunotherapy with BCG for recurrent malignant melanoma. Behring Inst. Mitt., 56: 199–206, 1975.
8.
IkonopisovR. L.: The use of BCG in the combined treatment of malignant melanoma. Behring Inst. Mitt., 56: 206–214, 1975.
9.
NathansonL.: Experience with BCG in malignant melanoma. Proc. Am. Ass. Cancer Res., 12: 99, 1971.
10.
PinskyC. M., HirshautY., OettgenH. F.: Treatment of malignant melanoma by intratumoral infection of BCG. Nat. Cancer Inst. Monogr., 39: 225–228, 1973.
